[1]
“IMPLEMENTING IAS 2 IN PHARMACEUTICAL ENTERPRISES: CHALLENGES AND BENEFITS”, ijpse, vol. 5, no. 03, pp. 542–549, Mar. 2026, doi: 10.55640/.